Chest
-
Respiratory Support PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Aerosol and humidification therapy are used in long-term airway management of critically ill patients with tracheostomy. The purpose of this study was to determine delivery efficiency of jet (JN) and mesh (MN) nebulizers combined with various humidification systems in a spontaneously breathing adult lung model with tracheostomy with or without exhaled humidity. ⋯ James Fink: Consultant fee, speaker bureau, advisory committee, etc.: Aerogen, Bayer, Boerhinger Ingleheim, Cubist, Dance Biopharm, Novartis, ONY, Parion, Aridis, and the WHO The following authors have nothing to disclose: Arzu AriNo Product/Research Disclosure Information.
-
BronchiectasisSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: To discuss the prevalence, risk factors and clinical features of bronchiectasis with NTM lung disease (NTMLD)METHODS: Retrospective analysis of the information of patients diagnosed as bronchiectasis or bronchiectasis with NTMLD from January 2009 to December 2012 in the electronic databases of the hospital. The demographic data, risk factors and clinical characteristics data were concluded and comparatively analyzed. Systematic analysis was performed in 192 cases who diagnosed as bronchiectasis with NTMLD. ⋯ The following authors have nothing to disclose: Jin-Fu Xu, Heping XiaoNo Product/Research Disclosure Information.
-
Respiratory Support PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: A variety of nebulizers and interfaces are used to administer medical aerosols to adults with pulmonary diseases. The purpose of this study was to determine the efficiency of a mesh nebulizer (MN) with adaptor and jet nebulizer (JN) using mouthpiece, valved-mask and open aerosol mask during simulated adult breathing parameters. ⋯ James Fink: Consultant fee, speaker bureau, advisory committee, etc.: Bayer, Boerhinger Ingleheim, Cubist, Dance Biopharm, Novartis, ONY, Parion, Aridis, and the WHO The following authors have nothing to disclose: Arzu Ari, Armele Dornelas de AndradeNo Product/Research Disclosure Information.
-
Infectious Disease Case Reports Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: An 85 year old male with CAD, severe aortic stenosis, sick sinus syndrome status post pacemaker and CHF, underwent a coronary artery bypass graft and an aortic valve replacement surgery with pericardial valve. He received a preoperative dose of IV vancomycin and cefazolin and 3 postoperative doses of cefazolin as part of the prophylactic protocol. On Hospital Day (HD) #4 he became septic and had several episodes of diarrhea with right lower quadrant abdominal pain. ⋯ We believe that the institution of IVIG was surgery averting for this patient with significant comorbidities even though it has only been described in case reports.Reference #1: J Salcedo, S Keates. Intraveous immunoglobilin therapy for severe Clostridium Difficile colitis. Gut 1997; 41: 366-370DISCLOSURE: The following authors have nothing to disclose: Nicolas Crescimone, Giri Srikanthanoff label use.
-
Critical Care Posters IIISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: We previously demonstrated in a clinically relevant murine model of sepsis, that animals with left ventricular (LV) dilation had better cardiovascular performance and increased survival. Using the same model of sepsis, we sought to determine if survivors have an early phenotype different from non-survivors with different resuscitation regiment. ⋯ The following authors have nothing to disclose: François Dépret, Fabien Picard, Sergio Zanotti-Cavazzoni, Steven HollenbergNo Product/Research Disclosure Information.